MDR-TB trial 6-month regimen appears effective

resisttb
Mar 25, 2021
1 min read

A trial aiming to find a better treatment for multidrug-resistant tuberculosis (MDR-TB) has stopped enrolling patients early after its independent data safety and monitoring board indicated that the regimen being studied is superior to current care, and more patient data was extremely unlikely to change the trial’s outcome. Read about it here.

Recent Posts

See All

International Course on the Clinical and Programmatic Management of DRTB

In person in Taipei in October 2025, by Prof Chen-Yuan Chiang. This course is essential for staff from National TB Programmes in charge...

USAid cuts could create untreatable TB bug ‘resistant to everything we have’

The Stop TB Partnership has raised alarms for the potential for new TB mutations associated with interruptions in care. The COVID...

World Health Organization warns of possible tuberculosis surge because of USAID cuts

A recent statement from the WHO warned of a spike in tuberculosis as a result of the shuttering of USAID. This trend can already be seen...

Comments